Editor-in-Chief: David D. Ho, MD
Paul A. Volberding, MD
William A. Blattner, MD
ISSN: 1525-4135
Online ISSN: 1077-9450
Frequency: 15 issues per year
Ranking: Infectious Diseases 10/70
Immunology 30/144
Impact Factor: 4.394
Featured Supplements

Guest Editors: 

Alan E. Greenberg

David W. Purcell

Christopher M. Gordon

Carlos del Rio

 

May 1, 2015 - Volume 69 - Supplement 1

Addressing the Challenges of the HIV Continuum of
Care in High Prevalence Cities in the United States

The overarching theme of this supplemental issue of JAIDS is addressing the challenges of the HIV continuum of care in high-prevalence cities in the United States. The supplement features an introductory article followed by 10 articles describing research projects conducted by National Institutes of Health (NIH)–supported Centers for AIDS Research (CFAR) and AIDS Prevention Center (APC) academic investigators, with their complementary biomedical and behavioral expertise, working largely in collaboration with their local public health departments. This supplemental issue describes the second series of studies to emerge from an NIH-funded initiative designed to increase collaborations among the CFARs, APCs, and local public health departments to inform and enhance outcomes in the HIV care continuum in settings where evidence-based practices are urgently needed. Results from the first series of studies were featured in a November 1, 2013 JAIDS Supplemental Issue.

Publication of this supplement was made possible by support from NIH

 

 

 Guest Editors:

 Jonathan E. Kaplan

Tiffany E. Hamm

April 15, 2015 - Volume 68 - Supplement 3

The Impact of HIV Care and Support Interventions on Key Outcomes in Low- and Middle-Income Countries

This special issue features 14 manuscripts that include evidence reviews and policy implications of HIV care and support interventions.   The series of articles are the result of a U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) convened technical working group comprised of HIV/AIDS experts who examined the impact of current care and support interventions on five outcomes — morbidity, mortality, retention in care, quality of life, and HIV transmission.  This considerable undertaking adds a depth to the HIV care and treatment literature that not only addresses the science, but the practical application of interventions countries need to inform policy decisions and maximize the impact of HIV care and treatment interventions. 

Publication of this supplement was made possible by support from PEPFAR.

Press Release

 

 

 

Current Issue Highlights

Actions
View
Actions
View
Login

Open Access

Information on

Open Access in JAIDS

2014 Top Reviewers

Basic Science 

Clinical Science 

Epi & Prevention 

Xueling

Wu

Esteban

Martinez

Jean Joel

Bigna Rim

Yaoxing

Huang

Steven

Grinspoon*

Nathan

Ford

Martin

Markowitz

Rebecca

Scherzer

Francesca

Bisio

Chasity

Andrews

Brookie

Best*

Jonathan

Feelemyer

Zhiwei

Chen

Christina

Wyatt

Shahul H.

Ebrahim

* Editorial Board Member

Thank you for

your outstanding service to JAIDS!

Webinar Panel Discussion

Strategic Roles for Health Communication in Combination HIV Prevention and Care Programs

Co-sponsored by Johns Hopkins’ Center for AIDS Research and Center for Communication Programs 

 

Webinar recording available

 

Read related content in Health Communication Strategies in Combination HIV Prevention and Care Programs

JAIDS Supplement, Vol. 66 Supplement 3

Journal Announcement

New Focus Area: Hepatitis B virus (HBV) and Hepatitis C virus (HCV)

JAIDS is now accepting manuscripts for a new focus area of interest: HBV and HCV  

The investment in HIV research has allowed us to make huge advances in controlling a formerly brutal epidemic. Now, what we've learned from HIV is being applied to hepatitis viruses, both HBV and especially HCV where curative treatments are on the verge of transforming that epidemic as well. JAIDS believes there is a clear synergy in these research efforts and that on all levels these research efforts are vital to share across the boundaries of interest of specific viral infections. JAIDS looks forward to publishing the best of this work and calls for manuscripts in HCV and HBV research as well as in ongoing work against HIV infection. 

View the latest Instructions to Authors.

Advances Relating to HIV Infection
 

Summaries of posters and presentations from ICAAC 2013

September 10 - 13, 2013

Denver, Colorado

 

Associate Director of the Institute of Human Virology, Director, Division of Epidemiology and Prevention

The University of Maryland School of Medicine Institute of Human Virology Division seeks a visionary leader with skills to manage and guide the Division of Epidemiology and Prevention and, as Associate Director, lead the mission of promoting the growth of the Institute and its multidisciplinary and translational research mission targeting chronic viral diseases, especially HIV/AIDS, and cancer especially virally linked cancer.

Position Announcement